Brown and beige fat cells are specialized adipocytes that generate heat (thermogenesis) and help prevent obesity and metabolic diseases. Brown adipocytes are found in dedicated depots and express high levels of thermogenic genes, while beige cells, also called 'brite' cells, develop in white fat in response to activators. Both types reduce metabolic disease in mice and correlate with leanness in humans. Many genes and pathways regulating these cells have been identified, offering therapeutic targets for metabolic diseases. Obesity, linked to numerous diseases, has increased due to sedentary lifestyles and calorie-dense diets. Brown adipose tissue (BAT) is crucial for thermogenesis in mammals, essential for survival in cold environments and arousal in hibernators. BAT cells contain uncoupling protein-1 (UCP1), which generates heat by uncoupling the electrochemical gradient. Beige adipocytes, found in white fat, also have thermogenic capacity and are regulated differently from brown cells. Brown and beige adipocytes differ in their embryonic origins, gene expression, and regulation. Brown cells express Ucp1 under basal conditions, while beige cells require activators like β-adrenergic agonists. Beige cells can be recruited from precursor cells, not from existing white fat cells. Beige adipocytes are abundant in inguinal white fat and can be induced by cold or β-adrenergic agonists. Prdm16 is a key regulator of brown fat development, and its expression is also important for beige fat development. Factors like Bmp7, TZDs, and miR-133 regulate Prdm16 and thus thermogenesis. PGC-1α is a master regulator of mitochondrial biogenesis and thermogenesis, activated by β-adrenergic signaling. Brown and beige fat play roles in regulating metabolism, including glucose tolerance and insulin sensitivity. Activating these tissues can improve metabolic health. However, the effectiveness of therapies targeting brown and beige fat in humans is still under investigation, with challenges including activation efficiency, compensatory mechanisms, and off-target effects. New factors like irisin, FGF21, and natriuretic peptides have been identified as potential activators of brown and beige fat. These factors show promise for therapeutic development but require further study. Therapies targeting brown and beige fat may offer new approaches for treating obesity and metabolic diseases.Brown and beige fat cells are specialized adipocytes that generate heat (thermogenesis) and help prevent obesity and metabolic diseases. Brown adipocytes are found in dedicated depots and express high levels of thermogenic genes, while beige cells, also called 'brite' cells, develop in white fat in response to activators. Both types reduce metabolic disease in mice and correlate with leanness in humans. Many genes and pathways regulating these cells have been identified, offering therapeutic targets for metabolic diseases. Obesity, linked to numerous diseases, has increased due to sedentary lifestyles and calorie-dense diets. Brown adipose tissue (BAT) is crucial for thermogenesis in mammals, essential for survival in cold environments and arousal in hibernators. BAT cells contain uncoupling protein-1 (UCP1), which generates heat by uncoupling the electrochemical gradient. Beige adipocytes, found in white fat, also have thermogenic capacity and are regulated differently from brown cells. Brown and beige adipocytes differ in their embryonic origins, gene expression, and regulation. Brown cells express Ucp1 under basal conditions, while beige cells require activators like β-adrenergic agonists. Beige cells can be recruited from precursor cells, not from existing white fat cells. Beige adipocytes are abundant in inguinal white fat and can be induced by cold or β-adrenergic agonists. Prdm16 is a key regulator of brown fat development, and its expression is also important for beige fat development. Factors like Bmp7, TZDs, and miR-133 regulate Prdm16 and thus thermogenesis. PGC-1α is a master regulator of mitochondrial biogenesis and thermogenesis, activated by β-adrenergic signaling. Brown and beige fat play roles in regulating metabolism, including glucose tolerance and insulin sensitivity. Activating these tissues can improve metabolic health. However, the effectiveness of therapies targeting brown and beige fat in humans is still under investigation, with challenges including activation efficiency, compensatory mechanisms, and off-target effects. New factors like irisin, FGF21, and natriuretic peptides have been identified as potential activators of brown and beige fat. These factors show promise for therapeutic development but require further study. Therapies targeting brown and beige fat may offer new approaches for treating obesity and metabolic diseases.